CCirculation3/30/2026Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide DataJonah Garry·Evan L. BrittainRead at CirculationTagsChronic Myeloid Leukemia TreatmentsHematology
